Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA-374a/forkhead box O1 signaling axis

Ovarian cancer is a prominent disease that demonstrates high incidence rates in women and often presents multidrug resistance. Propofol has been demonstrated to suppress the malignancy of various types of human cancer; however, the underlying molecular mechanisms of propofol in ovarian cancer remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yang, Peng, Yong-Bao, Ye, Ling-Ling, Ma, Long-Xian, Zou, Mei-Yan, Cheng, Zhong-Gui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003056/
https://www.ncbi.nlm.nih.gov/pubmed/32016462
http://dx.doi.org/10.3892/mmr.2020.10943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003056/
https://www.ncbi.nlm.nih.gov/pubmed/32016462
http://dx.doi.org/10.3892/mmr.2020.10943

Ejemplares similares